Apellis Pharmaceuticals (APLS) Q3 2024 Earnings

1AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-1.17
-0.88
-0.59
-0.3

Details

Expected EPS
-0.306225
Actual EPS
-0.3
Surprise EPS
0.01
Surprise Percent
+2.03%

Description

Apellis Pharmaceuticals (APLS) has reported earnings of -0.3 per share for Q3 2024.

0 Comments

Share your thoughts